Multiple Sclerosis by Hallam, Danial K.
UNIT A5.1Multiple Sclerosis
MRI is unquestionably the imaging modality of choice for evaluation of white matter
diseases. Although a routine brain MR exam would suffice in many applications, specific
protocols for multiple sclerosis have been developed to maximize its contribution. This
unit presents one such protocol while recognizing the wide opportunity for variation
depending on local clinical demand and personal preference.
BASIC
PROTOCOL
MULTIPLE SCLEROSIS
The basic goal in the evaluation of the suspected multiple sclerosis is one of plaque
identification followed by characterization. All demyelinating lesions exhibit T2 prolon-
gation, and so the exam begins with some form of T2 weighting. The choice of such
weighting, along with imaging plane, will be discussed. Although many approaches exist
for plaque characterization, they generally include a search for enhancement as a measure
of activity. Rather than being an all-or-none phenomenon, enhancement appears to be a
matter of degree, and so several tricks have evolved to maximize detection of enhance-
ment. These tricks, and their advantages and limitations, will be discussed. The parameters
given here are derived from experience at 1.5 T, and may need to be altered depending on
the field strength and the equipment manufacturer. The entire procedure generally takes
∼45 min.
Table A5.1.1 summarizes the six sequences which comprise the basic protocol along with
two optional sequences. Table A5.1.2 lists the hardware necessary to perform the proce-
dure. Next, stepwise instructions for performing the protocol are provided. The protocol
is not particularly demanding on scanner hardware and is of the sort which may be well
performed on most clinical systems.
NOTE: Be sure that technologists and nurses have immediate access to any equipment
such as crash carts or oxygen that may be necessary in the event of an emergency.
Materials
Normal saline (0.9% NaCl), sterile
Extravascular contrast agent (e.g., Magnevist, Omniscan, or Prohance)
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Table A5.1.1 Basic Multiple Sclerosis Protocola
Type of weighting and sequence Imagingplane
1. Pilot scan (scout) —
2. T1-weighted spin echo Sagittal
3. Fast FLAIR Sagittal
4. Dual echo PD/T2-weighted TSE/FSE Transverse
5. T1-weighted spin echo Transverse
6. Post-gadolinium T1-weighted spin echo Transverse
Optional sequences
7. Dual echo PD/T2-weighted CSE Transverse
8. T1-weighted MT spin echo Transverse
aAbbreviations: TSE, turbo spin echo; FSE, fast spin echo; CSE, con-
ventional spin echo; MT, magnetization transfer; FLAIR, fluid attenu-
ated inversion recovery; PD, proton density.
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Setup equipment and patient
1. Interview (screen) the patient to ensure that he or she has no contraindications such
as cardiac pacemakers or other implants containing ferromagnetic materials. Also be
sure to find out if the patient has any health conditions that may require the presence
of special emergency equipment or other precautions during the scanning procedure.
Generally standard screening forms are used for all patients scanned in a magnetic
resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants; see Shellock
(1996) for discussion of what implants may be safely scanned using magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
form.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Have the patient wash off mascara or other makeup to avoid local tissue heating and
image artifacts.
5. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet, and how to behave, including the following:
a. If earphones or headphones are used to protect the ears from the loud sounds
produced by the gradients, the patient will be asked to wear these, but will be able
to communicate with you at any time during the imaging.
b. The patient will be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For good results the patient should be instructed not to talk unless absolutely
necessary and to avoid or minimize swallowing and other movements during each
scan—i.e., as long as the banging sounds continue. Between scans, talking and
swallowing are acceptable in most cases, but should be avoided when comparative
positional studies are being performed; the patient will be informed when this is
the case.
d. Nevertheless, the patient may call out at any time if he or she feels it necessary.
6. Have the patient mount onto the table. Set up any triggering devices or other
monitoring equipment that is to be used either before or just after the patient lies
down.
Table A5.1.2 Equipment Parameters for MRI In Multiple
Sclerosis
Coil type Quadrature head coil
Gradient coil strength Whatever the system permits
Cardiac gating No
Peripheral monitoring For safety only
Respiratory gating No
Respirator If required by patient
Oxygen If required by patient
Motion cushions Useful
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7. Center the patient in the head coil. Make sure that the head and neck are constrained
to limit motion, especially if high-resolution scans are to be run.
Generally the patient’s head is fixed so that the head is horizontal (not tilted) and the neck
and head lie along the axis of the patient table; other positions may be appropriate
depending on the needs at hand.
8. If needed, place a pillow or other support under the knees to make the patient more
comfortable.
9. Establish an intravenous (i.v.) line from which the contrast agent can be injected, and
attach this line securely to the patient so that movement into or out of the magnet will
not pull at the patient’s arm.
This step may be performed prior to entering the magnet room if necessary to save scanner
time.
It is preferable to insert the line prior to imaging and to leave the patient in the magnet,
with no intervening motion between the scans run before contrast agent injection and those
run after injection.
10. Use the centering light to position the patient’s nasion and put him or her into the
center of the magnet.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
11. If the patient is unable to hold still, provide an appropriate sedative.
Sequence 1: Rapid three-plane positioning pilot
12. To validate the patient’s position, run the system’s pilot (or scout) scan to ensure
correct location of the head in three dimensions, using the imaging sequence given
in Table A5.1.3 or similar parameters.
Table A5.1.3 Parameters for Pilot Scan (Scout; Sequence 1)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) 3 planes
Central slice or volume center Run initially at magnet isocentera
Echo time (TE) Minimum
Repeat time (TR) Minimum
Flip angle (FA) 20°
Fields of view (FOVx, FOVy) 300 mm, 300 mm
Resolution (∆x, ∆y) 1.17 mm, 1.56 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 3, one in each of 3 cardinal planes
Slice gap Not applicable
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice locations Not applicable
Saturation pulses Not applicable
Scan time ∼10 sec
aIf the pilot scan shows the patient’s head to be significantly off-center, then it may be helpful to
reposition the patient and repeat the pilot scan.
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This sequence usually consists of three orthogonal planes to allow localization. The images
are often also used later to determine where to place the saturation pulses and to set up
total coverage of the volume of interest.
Sequence 2: T1-weighted spin echo sagittal
13. Using images generated in sequence 1, sagittal images are planned to provide whole
brain coverage. Set the parameters as indicated in Table A5.1.4.
The scan is best positioned first on the transverse pilot scan. Some angulation may be
needed to provide for true sagittal anatomic imaging. The coverage provided should then
be checked on the sagittal scout. This sequence is used to accurately position subsequent
scans. It provides excellent visualization of midline structures.
Sequence 3: Fast FLAIR sagittal
14. Set parameters for fast FLAIR sagittal as indicated in Table A5.1.5.
The scan is positioned just as in sequence 2. The sequence provides superior demonstration
of T2-weighted bright lesions, especially in the supratentorial compartment. The suppres-
sion of bright CSF (cerebrospinal fluid) afforded by the FLAIR technique demonstrates
lesions adjacent to CSF that would otherwise be poorly visualized. The use of the sagittal
plane for the study provides detailed visualization of lesions of the corpus callosum (Figure
A5.1.1). Such lesions are not only common in multiple sclerosis but are judged to be fairly
specific for this diagnosis (Gean-Marton et al., 1991).
Sequence 4: Dual echo PD/T2-weighted transverse
15. The T1-weighted sagittal image is used to position transverse scans. Set parameters
for the PD/T2-weighted dual echo transverse sequence as given in Table A5.1.6.
The scan is positioned graphically to provide whole brain coverage. The slices should be
angled according to an institutional standard for transverse images. The author recom-
mends using the “AC-PC” line as such a standard. Here, the anterior and posterior
commissures are identified on the T1-weighted sagittal midline image (Fig. A5.1.2). The
slices of all transverse scans are positioned parallel to a line drawn between the two
landmarks. The sequence provides excellent visualization of the whole brain. The trans-
verse plane is the most useful for evaluating demyelinating lesions involving the brainstem
(Figure A5.1.3). Proton-density weighting optimally visualizes lesions on the surface of the
brainstem, whereas the combination of T2-weighted and proton-density-weighted images
is best for deeper brainstem lesions. (FLAIR, although superior for evaluation of much
intracranial pathology, especially that adjacent to CSF, has proven less sensitive to
posterior fossa lesions; Bastianello et al., 1997; Tubridy et al., 1998).
Sequence 5: T1-weighted spin echo transverse
16. Set parameters for the T1-weighted spin echo transverse sequence as indicated in
Table A5.1.7 and position identically to sequence 4, dual PD/T2-weighted transverse
sequence.
The scan provides visualization of T1-weighted hypointense demyelinating lesions. Such
lesions have been shown to correlate better with the degree of disability than T2-weighted
lesions (van Walderveen et al., 1995; Truyen et al., 1996; Giugni et al., 1997). The
T1-weighted spin echo transverse image provides the appropriate comparison for evalu-
ation of contrast enhancement. Some demyelinating plaques, especially those that are
chronic, will exhibit borders of intrinsic T1-weighted hyperintensity (generally thought to
be evidence of myelin breakdown products). Without the benefit of a pre-contrast scan
performed identically to that post-contrast, differentiation of such areas of intrinsic
T1-weighted hyperintensity from true enhancement may not be possible.
17. Inject the contrast agent, then flush the intravenous line with 10 ml saline. It is
preferable to perform the contrast injection while leaving the patient in the magnet.
A dose of 0.1 mmol/kg of contrast agent is usually given. Triple dose (0.3 mmol/kg) may
be used to improve demonstration of enhancement.
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Sequence 6: T1-weighted spin echo post-contrast transverse
18. Simply repeat sequence 5 after injecting contrast using the parameters as given in
Table A5.1.7.
Gadolinium administration is not generally necessary for the diagnosis of multiple sclero-
sis but it is very helpful for assessment of disease activity, as only acute lesions enhance.
Several techniques exist which are meant to provide more sensitive evaluation of the
breakdown of blood-brain barrier indicated by enhancement. Use of triple the usual dose
Table A5.1.4 Parameters for T1-Weighted Spin Echo Sagittal (Sequence 2)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Midline
Echo time (TE) 14 msec
Repeat time (TR) 600 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 230 mm, 230 mm
Resolution (∆x, ∆y) 1.2 mm, 0.9 mm
Number of data points collected (Nx, Ny) 192, 256
Slice thickness (∆z) 5 mm
Number of slices 19–21
Slice gap (distance factor) 1.5 mm (0.30)
Number of acquisitions (Nacq) 1
Read direction Cranio-caudal
Saturation pulses Inferior may be used
Scan time ∼2 min
Table A5.1.5 Parameters for Fast FLAIR Sagittal (Sequence 3)
Patient position Supine
Scan type Fast FLAIR
Imaging plane (orientation) Sagittal
Central slice or volume center Midline
Echo time (TE)a 100–140 msec
Echo train length (ETL) (turbo factor) 7–11
Repeat time (TR)a 8,000–10,000 msec
Inversion time (TI)a 2300 msec
Flip angle (FA) 180°
Fields of view (FOVx, FOVy) 230 mm, 230 mm
Resolution (∆x, ∆y) 0.9 mm, 0.9 mm
Number of data points collected (Nx, Ny) 256, 256
Slice thickness (∆z) 4–5 mm
Number of slices 21
Slice gap 1.5 mm (or run twice and
interleave with zero gap)
Number of acquisitions (Nacq) 1
Read direction Cranio-caudal
Saturation pulses Inferior may be used
Scan time ∼4 min
aOptimum choice of parameters for fast FLAIR varies significantly with manufacturer and scanner
limitations. For a review of parameter optimization in fast FLAIR (see Rydberg et al., 1995).
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of gadolinium is likely the most powerful technique (Bastianello et al., 1998). Please see
discussion of augmenting enhancement under Commentary.
Sequence 7: Dual echo PD/T2-weighted conventional spin echo (optional)
19. Sequence 7 may be used in lieu of sequence 4 using parameters in Table A5.1.8.
The sequence will require more scanning time than the FSE/TSE and a larger slice gap is
required to provide whole brain imaging. It is comparable in lesion detection to sequence
4 (see discussion in the Commentary).
Figure A5.1.1 Fast FLAIR sagittal provides optimal
visualization of small callosal multiple sclerosis lesions
sometimes referred to as subependymal striations.
Table A5.1.6 Parameters for Dual Echo PD/T2-Weighted TSE/FSE Transverse
(Sequence 4)
Patient position Supine
Scan type TSE/FSE
Imaging plane (orientation) Transverse
Central slice or volume center Position for whole brain coverage
Echo time (TE) 14–17 msec for PD-weighted
image and 85–102 msec for
T2-weighted image
Echo train length (ETL) (turbo factor) 5–8
Repeat time (TR) 2500–3000 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mm, 230 mm
Resolution (∆x, ∆y) 0.94 mm, 0.90 mm
Number of data points collected (Nx, Ny) 192, 256
Slice thickness (∆z) 5 mm
Number of slices 23
Slice gap (distance factor) 1.5 mm (0.30)
Number of acquisitions (Nacq) 1
Read direction Anterior to posterior
Saturation pulses Inferior may be used
Scan time ∼3 min
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Figure A5.1.2 Midline T1-weighted sagittal image demonstrates placement of AC-PC line
to be used to position transverse images.
A B
Figure A5.1.3 Combination of PD (A) and T2-weighted (B) transverse images demonstrates even
very small brainstem lesions as shown here in the ventral medulla. Such lesions are important for
several reasons. Brainstem lesions are frequently clinically apparent and imaging confirmation is
generally preferred by the clinician. Also, multiple sclerosis brainstem lesions are often located along
the cisternal or ventricular surface—a feature atypical for senescent/ischemic lesions.
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Sequence 8: T1-weighted magnetization transfer spin echo transverse (optional)
20. Run sequence 8 using parameters in Table A5.1.9 and position similarly to other
transverse sequences.
The increased time required for the magnetization transfer pulse increases TR and reduces
the maximum number of slices. An increase in number of acquisitions is generally needed
for satisfactory image quality.
Table A5.1.7 Parameters for T1-Weighted Spin Echo Transverse (Sequences 5
and 6)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Position for whole brain coverage
Echo time (TE) 14 msec
Repeat time (TR) 600 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mm, 230 mm
Resolution (∆x, ∆y) 0.94 mm, 0.90 mm
Number of data points collected (Nx, Ny) 192, 256
Slice thickness (∆z) 5 mm
Number of slices 23
Slice gap (distance factor) 1.5 mm (0.30)
Number of acquistitions (Nacq) 1
Read direction Anterior to posterior
Saturation pulses Inferior may be used
Scan time ∼3 min
Table A5.1.8 Parameters for Dual Echo PD/T2-Weighted Conventional Spin
Echo (Sequence 7)
Patient position Supine
Scan type Conventional spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Position for whole brain coverage
Echo time (TE) 30 msec for PD-weighted image
and 80 msec for T2-weighted
image
Repeat time (TR) 2500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mm, 230 mm
Resolution (∆x, ∆y) 0.94 mm, 0.90 mm
Number of data points collected (Nx, Ny) 192, 256
Slice thickness (∆z) 5 mm
Number of slices 20
Slice gap (distance factor) 2.5 mm (0.50)
Number of acquisitions (Nacq) 0.75a
Read direction Anterior to posterior
Saturation pulses Inferior may be used
Scan time ∼5 min
aRefers to 3/4 NEX imaging, also known as partial Fourier imaging—an option available on many
clinical scanners. Partial Fourier imaging reduces imaging time by exploiting the inherent symmetry
of k-space; essentially, fewer phase encoding steps are used to provide the same spatial resolution. The
time saved is at the expense of signal to noise.
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Magnetization transfer imaging has multiple potential uses in everyday clinical imaging
of multiple sclerosis and still more in the investigational arena. In routine use, MT may be
helpful in improving specificity in the diagnosis (Mehta et al., 1996) of periventricular
demyelinating lesions (Fig. A5.1.4). Also, it is one of the tricks used to augment enhance-
ment. Both of these issues are discussed in further detail under Commentary.
Table A5.1.9 Parameters for T1-Weighted Magnetization Transfer Spin Echo
Transverse (Sequence 8)
Patient position Supine
Scan type Spin echo with MT pulse
Imaging plane (orientation) Transverse
Central slice or volume center Position for whole brain coverage
Echo time (TE) 15 msec
Repeat time (TR) 715 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mm, 230 mm
Resolution (∆x, ∆y) 0.94 mm, 0.90 mm
Number of data points collected (Nx, Ny) 192, 256
Slice thickness (∆z) 5 mm
Number of slices 19
Slice gap (distance factor) 1.5 mm (0.30)
Number of acquisitions (Nacq) 2
Read direction Anterior to posterior
Saturation pulses Inferior may be used
Scan time ∼5 min
A B
Figure A5.1.4 T2-weighted TSE transverse (A) and T1-weighted MT spin echo transverse (B)
images demonstrate multiple callosal and periventricular lesions in this patient with multiple
sclerosis. The increased signal on the T1-weighted MT sequence is seen in some but not all
demyelinating lesions. It is not generally seen with senescent/ischemic lesions and so is somewhat
specific for demyelinating disease. 
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COMMENTARY
Background Information
Owing to its high incidence, chronicity, and
tendency to attack young adults, multiple scle-
rosis is one of the most important neurologic
diseases. Although the exact cause is yet to be
elucidated, autoimmune mechanisms and ge-
netic susceptibility are generally regarded to be
central. Prevalence increases with latitude, and
clear racial differences exist with Caucasians at
greatest risk. In the United States, individuals
have a one in one thousand risk of developing
multiple sclerosis during their lifetime. Annual
costs related to the disease, including loss of
productivity, rehabilitation, and medical care,
have been estimated at over 2.5 billion dollars.
MRI has fundamentally altered the evalu-
ation of this patient population. Whereas in the
past, multiple sclerosis diagnosis rested solely
upon clinical criteria, current evaluation and
treatment monitoring always include MRI.
Sensitivity to changes in water content, the
hallmark of MR, allows for detection of lesions
missed by other imaging techniques. MRI also
demonstrates lesion activity through the use of
contrast administration and allows for more
specific diagnosis of demyelinating lesions.
MRI has altered the understanding of multiple
sclerosis by revealing its dynamic nature, in
which lesions progess and resolve undetected
clinically.
The importance of multiple sclerosis and the
central role played by MRI have conspired to
generate myriad investigations directed at im-
proving the contribution of MRI to evaluation
and management. MR techniques applied to
multiple sclerosis include magnetization trans-
fer, proton spectroscopy, phosphorus spectros-
copy, lesion volume quantitation, and diffusion
anisotropy. Some of these techniques have al-
ready contributed to our understanding of mul-
tiple sclerosis and hold promise for more in the
future. Despite these advances, protocols for
basic clinical evaluation consist primarily of
some form of T2-weighted imaging, and, when
appropriate, gadolinium enhancement.
Use of fast FLAIR
T2-weighted imaging provides superior
parenchymal contrast in brain imaging. How-
ever, small T2-weighted hyperintense lesions
may be obscured by adjacent, normally bright
structures, most notably CSF. FLAIR (Fluid
Attenuated Inversion Recovery) was developed
to overcome this limitation through use of a
magnetization preparation pulse applied prior
to initiation of a T2-weighted imaging se-
quence. Here, an inversion recovery pulse is
applied and the spins are then allowed to relax
back partially to the equilibrium state as defined
by their T1 characteristics. The imaging se-
quence is begun after a delay, TI for inversion
time, when the tissue to be suppressed is at the
null point (effectively, with no net longitudinal
magnetization) on its course back to equilib-
rium. In FLAIR the TI is chosen so that CSF is
at the null point. The end result is a predomi-
nantly T2-weighted image with CSF sup-
pressed through exploitation of its T1 relaxation
characteristics.
The T1 of CSF is long, so a fairly long time
(2000 to 2500 msec) must elapse between the
inversion recovery pulse and the initiation of
the imaging sequence. In early implementation,
FLAIR was used with a spin echo sequence.
Although the advantage of the technique was
demonstrated, the imaging time (greater than
10 min) was too long to gain widespread ac-
ceptance (Hajnal et al., 1992). More recently,
FLAIR has been implemented with FSE/TSE
sequence (fast FLAIR) yielding acceptable im-
aging times.
Considering the propensity of multiple scle-
rosis lesions to occur near ventricles, one might
predict a sequence which suppresses the bright
signal of CSF to uncover subtle periventricular
lesions. Numerous studies have supported this
expectation, and fast FLAIR is now widely
regarded as providing superior sensitivity to
supratentorial demyelinating lesions. Some-
what surprisingly, the same cannot be stated for
infratentorial lesions. Several studies have
demonstrated relative insensitivity of fast
FLAIR in the posterior fossa (Bastianello et al.,
1997; Tubridy et al., 1998). In light of this
limitation, and recognizing the clinical impor-
tance of identifying posterior fossa lesions, a
dual-echo PD/T2-weighted transverse se-
quence is included as a key component of the
recommended protocol.
Use of sagittal plane
Evaluation of the corpus callosum in the
sagittal plane enhances detection of subtle le-
sions and provides some specificity to the di-
agnosis of demyelinating disease relative to
other periventricular white matter diseases
(Gean-Marton et al., 1991; Jackson et al., 1993;
Hashemi et al., 1995; Palmer et al., 1999). A
scan in the sagittal plane is now expected by
our referring clinicians whenever multiple scle-
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rosis is clinically suspected. Considering the
advantage of fast FLAIR in evaluating periven-
tricular disease, as well as its limitations in the
brainstem, the sequence is applied to best ad-
vantage sagittally (Figure A5.1.1).
The choice of slice thickness for fast FLAIR
sagittal evokes another discussion. With some-
what thicker slices (4 to 5 mm), whole brain
coverage is conveniently achieved. Although
the focus of the scan is to evaluate the corpus
callosum, complete brain coverage may un-
cover small subcortical lesions not readily ap-
parent on the PD/T2-weighted transverse im-
ages. Use of thinner slices (3 mm or even 2 mm)
brings out subtle subependymal striations ad-
vocated by some as representing early demyeli-
nation which might not otherwise be detected
(Hashemi et al., 1995). Use of such thin slices
requires increasing the number of acquisitions
to achieve reasonable image quality. In the
author’s experience, the potential benefit does
not warrant the additional imaging time re-
quired.
RARE (rapid acquisition and resolution
enhancement) versus conventional spin echo
Hennig et al. (1986) demonstrated a tech-
nique for diminishing scan time in which mul-
tiple spin echos were measured for a given
excitation (that is, multiple lines of k-space)
rather than one spin echo, as is the case with
conventional spin echo. The train of spin echos
was created through the use of a series of 180°
inversion pulses which were applied after the
creation of each echo. Originally labeled
RARE for Rapid Acquisition and Resolution
Enhancement, the approach is now more com-
monly known by manufacturer labels—fast
spin echo (FSE) and turbo spin echo (TSE).
Although clearly faster, early implementations
proved less sensitive in detection of demyeli-
nating plaques. Following further evaluation, it
became apparent that the problem resided not
with the concept but rather with the long TR
values (4000 msec or greater) initially em-
ployed. With proper choice of parameters,
TSE/FSE is very similar to the conventional
spin echo method in lesion detection, while
maintaining the advantage of reduced imaging
time (Thorpe et al., 1994). Conventional spin
echo imaging is comparable in lesion detection
and so is left as an alternative to TSE/FSE in
the recommended protocol.
Augmenting enhancement
Acute multiple sclerosis lesions are primar-
ily inflammatory and carry with them a local
disruption in the blood-brain barrier. Gadolin-
ium enhancement on MRI provides a conven-
ient marker for this disruption and correlates
well with the presence of acute inflammation
(Fig. A5.1.5; Nesbit et al., 1991; Katz et al.,
1993). MRI thereby detects early events in the
inflammatory process leading eventually to
myelin loss and other tissue destruction (Tro-
jano et al., 1996; Giovannoni et al., 1997).
Reflecting the importance of demonstrating
lesion activity in multiple sclerosis, the efficacy
of several techniques in improving detection of
enhancement has been investigated. Tech-
niques so investigated include triple-dose gad-
olinium, delayed imaging, and magnetization
transfer (MT; see below) (Silver et al., 1997;
Bastianello et al., 1998; Filippi et al., 1998a,b;
Rovaris et al., 1998; Rovaris et al., 1999a,b).
Of these techniques, triple-dose gadolinium is
most effective, with several studies document-
ing significant increases ranging from 50% to
100% in the number of enhancing lesions de-
tected. Delayed imaging and MT have some
effect and may be particularly useful in combi-
nation. Each technique, of course, carries some
penalty. For triple-dose gadolinium, the down-
side is simply one of increased cost. Delayed
imaging alone is only mildly effective and of
course requires additional time (20 min or
more) for the delay (Silver et al., 1997). For
MT, proper interpretation of the presence of
enhancement necessitates performance of a
pre-contrast MT scan. Some of these tech-
niques are currently in use in clinical trials but
are not, so far, part of standard clinical practice.
They are therefore left as options.
Contribution of magnetization transfer (MT)
Protons in water may be detected using
conventional MRI because they spin or precess
at nearly the same frequency. These detectable
protons are relatively “free” at the molecular
level. A second population of protons exists,
but for our purposes may only be detected
indirectly. This second population consists of
protons “bound” to complex macromolecules.
The association with these macromolecules
modulates the magnetic microenvironment of
the “bound” protons, causing them to spin at
varying frequencies. With this variation in fre-
quency the protons cannot be directly meas-
ured. However, the magnetizations of the
“bound” and “free” populations are not sepa-
rate, and will exchange to some extent (Wolff
and Balaban, 1989). Because of this exchange,
manipulations of the signal of one group will
be transferred to the other.
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Several types of MT pulses exist. In the most
conceptually straightforward approach, an off-
resonance saturation pulse is applied to the
“bound” population. This saturation will be
exchanged with the measurable “free” popula-
tion, thereby partially decreasing their signal.
The extent of the exchanged saturation depends
on factors relating both to the saturation pulse
and to the tissue to which it is applied. Tissues
with higher number of “bound” protons (i.e.,
white matter) will be more effected by the
magnetization pulse. Pathology, including de-
myelination, decreases the number of bound
protons to be saturated and thereby diminishes
the magnetization transfer effect. These effects
provide several opportunities for application of
MT to improve evaluation of white matter le-
sions. Such applications include but are not
limited to: (1) improved sensitivity to enhance-
ment, (2) improved specificity in diagnosis of
multiple sclerosis plaques versus other periven-
tricular white matter disease, and (3) further
characterization of underlying pathology in
multiple sclerosis plaques. Of these, in the
author’s opinion, the first two items are closest
to becoming part of usual clinical practice and
will be discussed below.
MT may be used to augment enhancement,
predominantly by selectively suppressing
nonenhancing structures. The application of
MT has been shown to approximately double
the contrast-to-noise ratio of enhancing lesions
compared with non-MT spin echo imaging
(Finelli et al., 1994). The MT effect is not
limited to enhancement, and nonenhancing le-
sions may exhibit increased signal on MT im-
ages. For this reason, precontrast MT imaging
is needed to validly diagnose enhancement
(Mehta et al., 1995).
MT may be helpful in distinguishing de-
myelinating lesions from periventricular white
matter ischemic lesions. This follows from the
increased MT effect in white matter ischemic
lesions compared with demyelinating lesions
of multiple sclerosis (Mehta et al., 1996). With
the MT effect higher in ischemic white matter
lesions, such lesions are suppressed along with
normal brain, more so than demyelinating le-
sions. When inspecting MT T1-weighted spin
echo images, the difference translates into high
signal in some demyelinating lesions, but the
contrast between white matter and gray matter
is suppressed (Figure A5.1.4). In general, mul-
tiple sclerosis is usually recognized by consid-
ering lesion distribution and morphology in
conjunction with the clinical setting. In those
cases in which such considerations are insuffi-
cient for confident diagnosis, MT may be a
helpful option.
A B
Figure A5.1.5 T2-weighted TSE transverse (A) and post-contrast T1-weighted spin echo trans-
verse (B) images demonstrate typical enhancing demyelinating plaque. Contrast enhancement can
be subtle in multiple sclerosis. Performance of T2-weighted transverse sequence in identical location
as post-contrast T1-weighted transverse sequence aids recognition of enhancing lesions.
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Critical Parameters and
Troubleshooting
Motion artifacts may be a problem for nearly
any MRI examination. Some motion may be
present without significantly compromising
the diagnostic utility of the examination. More
frequent motion will be a problem. Proper care
in placing and securing the patient in the head
coil is critical, as is the interaction of the MRI
technologist with the patient. In cases in which
such measures are insufficient, prudent con-
scious sedation should be employed if at all
possible. If sedation fails or is not possible, then
faster imaging may be considered. As a first
step, the provided sequences may be shortened
simply by reducing the acquisition matrix (Nx,
Ny). Fast imaging techniques do exist and will
be described in a later unit. However, such
techniques are particularly limited in matters
of contrast and are clearly inferior in evaluating
white matter disease.
Proper contrast in fast FLAIR imaging is
central to the recommended protocol. As noted
previously, manufacturers vary in their imple-
mentation of this sequence, including the pa-
rameters employed. Utilization of FLAIR
should begin with the manufacturer’s standard
parameters. Beyond this, some modifications
may yield more appealing images with im-
proved T2-weighted lesion contrast. Use of a TR
that is too low (i.e., <7000 msec) compromises
both T2-weighted contrast and CSF suppres-
sion. The TE should be fairly long, at least 100
msec, again for reasons related to T2-weighted
contrast. The inversion time (TI) is dictated by
the T1 of CSF and for a 1.5 Tesla magnet should
be between 2100 msec and 2400 msec. See
Rydberg et al. (1995) for a thorough discussion
of the considerations involved.
As already indicated, in early implementa-
tions of TSE/FSE, the TR and TE values chosen
were too long to provide good T2-weighted
lesion contrast. TR and TE values should be
chosen that are not longer than those given in
Table A5.1.6. Use of longer relaxation parame-
ters yields images which are visually accept-
able; however fairly extensive experience
proves that sensitivity to T2-weighted hyperin-
tense lesions is compromised.
Phase-encoding artifacts may occasionally
be problematic in the posterior fossa on post-
contrast images. Use of flow compensation
usually solves such problems. Flow compensa-
tion requires a small increase in TE (up to ∼17
msec). Such a parameter change does not di-
minish image quality. Alternatively, the addi-
tion of a post-contrast T1-weighted scan in a
different plane, usually coronal, generally al-
lows definitive interpretation of the presence of
enhancement.
Anticipated Results
The exam should provide full imaging char-
acterization of brain-parenchymal demyelinat-
ing lesions. To accomplish this end, effectively
three types of sequences with various T2
weighting are employed: fast FLAIR, proton
density, and T2. Each of these is performed in
the plane in which it is most useful. Lesions of
the corpus callosum, especially at the callosal-
septal interface, are optimally visualized by
FLAIR performed in the sagittal plane. Other
periventricular lesions are well visualized on
both the sagittal FLAIR and the PD/T2-
weighted transverse images. Lesion activity, as
manifested by blood-brain barrier compromise,
will be demonstrated by the presence of en-
hancement.
The exam is not intended to optimally detect
optic neuritis. Generally, this is not an impor-
tant imaging indication as its diagnosis is clini-
cally readily apparent and the MRI is usually
employed to evaluate for the presence of other
clinically occult lesions. If evaluation for optic
neuritis is the clinical indication, then a dedi-
cated orbit exam should be performed (see UNIT
A7.5).
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